US Patent 10160799 Humanized tau antibodies in a alzheimer's disease
Patent 10160799 was granted and assigned to AXON Neuroscience on December, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 11 Feb, 2024
Megan Gustafson
Megan Gustafson
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+312 characters)
Article
Patent abstract
The present invention is in the fields of biochemistry, molecular biology, and Alzheimer's disease diagnosis, prevention, and treatment Provided herein are humanized antibodies against human tau that are capable of discriminating between normal (healthy) and pathological (disease-associated) tau.
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
101607990
Date of Patent
December 25, 2018
0Patent Application Number
155283330
Date Filed
November 18, 2015
0Patent Citations Received
Patent Primary Examiner
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
101607990
Date of Patent
December 25, 2018
0Patent Application Number
155283330
Date Filed
November 18, 2015
0Patent Citations Received
Patent Primary Examiner
Golden AI
Infobox
Patent Citations Received
Edits on 29 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10160799 Humanized tau antibodies in a alzheimer's disease
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10160799
Date of patent
December 25, 2018
Patent application number
15528333
Date Filed
November 18, 2015
Patent primary examiner
Find more entities like US Patent 10160799 Humanized tau antibodies in a alzheimer's disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
